ThermoFisherScientific - Custom and Bulks
Pharma Focus Europe
Worldwide Clinical Trials - Oncology

LATEST NEWSRead more...

02

May 2024

Scenic Biotech Partners with Bristol Myers Squibb for Research Collaboration

Scenic Biotech a leader in the field of modifier therapies for severe genetic disorders has announced a research collaboration with Bristol Myers Squibb aimed at accelerating the development of drug targets owned by Bristol Myers Squibb The collaboration will focus on identifying target biology

02

May 2024

Creyon Bio and Cajal Neuroscience Enter Collaboration to Develop Oligonucleotide-Based Therapies for Neurodegenerative Conditions

Creyon Bio Inc and Cajal Neuroscience have recently announced a collaborative effort to develop innovative treatments for neurodegenerative diseases Creyon specializes

01

May 2024

01

May 2024

Caris Life Sciences and COTA, Inc. Team Up to Broaden Collective Multi-Modal Data Offerings

Caris Life Sciences a leader in AI TechBio and precision medicine has partnered with COTA Inc an oncology realworld data and analytics firm to enhance their multimodal data offerings

30

Apr 2024

Avenacy Launches Eptifibatide Injection in the U.S. Market

Avenacy a pharmaceutical company specializing in critical injectable medications has introduced Eptifibatide for Injection in the United States This medication approved by the US Food and Drug Administration serves as a generic equivalent for Integrilin for Injection

29

Apr 2024

RenAgade Therapeutics expands its dedication to glycobiology through the establishment of GanNA Bio

ReNAgade Therapeutics is broadening its scope in RNA medicine through a collaboration with GanNA Bio This partnership aims to explore the potential of glycobiology in therapeutic applications

press releasesRead more...

Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition

Repare Therapeutics Inc a leading clinicalstage precision oncology company and Debiopharm a privatelyowned Swissbased biopharmaceutical company

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

Astellas Pharma Inc and Poseida Therapeutics Inc today announced that Xyphos Biosciences Inc and Poseida have entered into a research collaboration

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib

G Therapeutics Inc a commercialstage oncology company and Pepper Bio the worlds first transomics drug discovery and development company announced a global licensing agreement

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

Collegium Pharmaceutical Inc a leading diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical

02 - 03

May 2024

02 - 03

May 2024

02 - 03

May 2024

06 - 07

May 2024

06 - 07

May 2024

07 - 09

May 2024

CPHI North America

Pennsylvania, USA

08 - 09

May 2024

13 - 17

May 2024

20th Annual PEGS Boston

Boston, MA, USA

patheon - Mastering API production at every scale
7th Pharma Packaging and Labelling Forum 2024
Future Labs Live - 2024
World Orphan Drug Congress 2024
World Vaccine Congress Europe 2024
Sartorius Webinar - Pave Your Weigh to Accurate Analytical Results
EUROPEAN PHARMA OUTSOURCING SUMMIT 2024
patheon - Revolutionizing Pharma

TOP ARTICLES

  • 1

    Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    Unlocking Value: Data Science Applications in Pharmacoeconomics

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    The Synergy of Bioinformatics and Computational Biology in Genome Analysis

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    Optimizing Pharmaceutical Viral Vector Production: Techniques and Challenges

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    How Can Smart Packaging Revolutionize Pharma with Track-and-Trace Solutions?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

EDITORIAL SECTION